BH_NonClinical_Pharmacy_Car-T
Buyer: Barts Health NHS Trust
- Published
- 26 November 2025
- Estimated value
- £2,100,000
- Procedure
- Direct award
- Lots
- 1
- Notice number
- 077086-2025
- Reference
- ocds-h6vhtk-05e8d3
- Official source
- Official source
CPV codes
- 33000000Medical equipments, pharmaceuticals and personal care products
- 85149000Pharmacy services
Description
CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED | £2,100,000 | — |
Official publications
- FTS · 077086-2025 · 26 November 2025
Other tenders from Barts Health NHS Trust
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £2,100,000.
- Who is the buyer of this tender?
- The contracting authority is Barts Health NHS Trust (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.